Beijing Prohibits Drug Price Mark-up Beyond 15 Percent
This article was originally published in PharmAsia News
Executive Summary
Beijing's Development and Reform Commission recently announced that all municipal county-level and higher medical institutions will be strictly prohibited from increasing drug prices beyond 15 percent of actual procurement prices